FDA Reluctantly Grants Teva Exclusivity For Cozaar And Hyzaar Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency says it has no choice but to award Teva exclusivity given an appeals court decision limiting forfeiture; Apotex has not decided whether it will challenge the court's ruling.